25 XP   0   0   10

Biovie Inc
Buy, Hold or Sell?

Let's analyse Biovie Inc together

PenkeI guess you are interested in Biovie Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biovie Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biovie Inc

I send you an email if I find something interesting about Biovie Inc.

Quick analysis of Biovie Inc (30 sec.)










What can you expect buying and holding a share of Biovie Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
12.5%

What is your share worth?

Current worth
$0.14
Expected worth in 1 year
$-0.20
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.34
Return On Investment
-66.9%

For what price can you sell your share?

Current Price per Share
$0.51
Expected price per share
$0.445 - $1
How sure are you?
50%

1. Valuation of Biovie Inc (5 min.)




Live pricePrice per Share (EOD)

$0.51

Intrinsic Value Per Share

$-7.79 - $-3.26

Total Value Per Share

$-7.65 - $-3.13

2. Growth of Biovie Inc (5 min.)




Is Biovie Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$7.4m$11.4m$1.6m12.4%

How much money is Biovie Inc making?

Current yearPrevious yearGrowGrow %
Making money-$10.8m-$10.8m-$40.1k-0.4%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Biovie Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#702 / 1010

Most Revenue
#893 / 1010

Most Profit
#581 / 1010

Most Efficient
#333 / 1010

What can you expect buying and holding a share of Biovie Inc? (5 min.)

Welcome investor! Biovie Inc's management wants to use your money to grow the business. In return you get a share of Biovie Inc.

What can you expect buying and holding a share of Biovie Inc?

First you should know what it really means to hold a share of Biovie Inc. And how you can make/lose money.

Speculation

The Price per Share of Biovie Inc is $0.5054. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biovie Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biovie Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.14. Based on the TTM, the Book Value Change Per Share is $-0.08 per quarter. Based on the YOY, the Book Value Change Per Share is $0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biovie Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.15-30.3%-0.17-33.6%-0.19-37.1%-0.28-55.6%-0.14-28.3%
Usd Book Value Change Per Share0.00-0.2%-0.08-16.7%0.059.0%0.000.7%0.000.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.1632.0%0.0816.0%
Usd Total Gains Per Share0.00-0.2%-0.08-16.7%0.059.0%0.1732.8%0.0816.7%
Usd Price Per Share1.26-4.27-4.11-6.45-3.31-
Price to Earnings Ratio-2.06--6.28--5.44--19.05--18.62-
Price-to-Total Gains Ratio-1,220.70--345.97-6.46--107.44--88.02-
Price to Book Ratio9.24-17.48-21.76-18.52--274.46-
Price-to-Total Gains Ratio-1,220.70--345.97-6.46--107.44--88.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.5054
Number of shares1978
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.16
Usd Book Value Change Per Share-0.080.00
Usd Total Gains Per Share-0.080.17
Gains per Quarter (1978 shares)-167.25327.44
Gains per Year (1978 shares)-669.011,309.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-669-6791281281300
20-1338-13482563572610
30-2007-20173844853920
40-2676-268651251145230
50-3345-335564061426540
60-4014-402476881717850
70-4683-469389691999160
80-5352-53621025022810470
90-6021-60311153225611780
100-6690-67001281328513090

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.039.00.02.5%1.041.00.02.4%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%5.015.00.025.0%8.030.02.020.0%9.031.02.021.4%
Dividend per Share0.00.04.00.0%1.00.011.08.3%4.00.016.020.0%5.00.035.012.5%5.00.037.011.9%
Total Gains per Share0.04.00.00.0%4.08.00.033.3%8.012.00.040.0%12.027.01.030.0%13.028.01.031.0%

Fundamentals of Biovie Inc

About Biovie Inc

BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Fundamental data was last updated by Penke on 2024-04-11 02:15:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Biovie Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biovie Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biovie Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY--288.3%+288.3%
5Y--449.1%+449.1%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Biovie Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • -39.1% Return on Assets means that Biovie Inc generated $-0.39 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biovie Inc:

  • The MRQ is -39.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -36.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-39.1%TTM-36.0%-3.1%
TTM-36.0%YOY-36.5%+0.6%
TTM-36.0%5Y-167.7%+131.8%
5Y-167.7%10Y-94.4%-73.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-39.1%-13.3%-25.8%
TTM-36.0%-12.8%-23.2%
YOY-36.5%-11.7%-24.8%
5Y-167.7%-13.9%-153.8%
10Y-94.4%-15.7%-78.7%
1.1.3. Return on Equity

Shows how efficient Biovie Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • -112.2% Return on Equity means Biovie Inc generated $-1.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biovie Inc:

  • The MRQ is -112.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -95.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-112.2%TTM-95.9%-16.3%
TTM-95.9%YOY-123.5%+27.6%
TTM-95.9%5Y-180.2%+84.3%
5Y-180.2%10Y-132.5%-47.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-112.2%-16.9%-95.3%
TTM-95.9%-16.1%-79.8%
YOY-123.5%-15.1%-108.4%
5Y-180.2%-19.3%-160.9%
10Y-132.5%-20.2%-112.3%

1.2. Operating Efficiency of Biovie Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biovie Inc is operating .

  • Measures how much profit Biovie Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biovie Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y--492.1%+492.1%
10Y--632.4%+632.4%
1.2.2. Operating Ratio

Measures how efficient Biovie Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biovie Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-3.890-3.890
5Y-5.739-5.739
10Y-7.876-7.876

1.3. Liquidity of Biovie Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biovie Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.47 means the company has $1.47 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biovie Inc:

  • The MRQ is 1.471. The company is just able to pay all its short-term debts.
  • The TTM is 2.074. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.471TTM2.074-0.603
TTM2.074YOY5.354-3.281
TTM2.0745Y8.763-6.690
5Y8.76310Y8.591+0.172
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4713.890-2.419
TTM2.0744.173-2.099
YOY5.3545.344+0.010
5Y8.7636.126+2.637
10Y8.5916.448+2.143
1.3.2. Quick Ratio

Measures if Biovie Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • A Quick Ratio of 1.45 means the company can pay off $1.45 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biovie Inc:

  • The MRQ is 1.447. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 2.478. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.447TTM2.478-1.031
TTM2.478YOY5.300-2.822
TTM2.4785Y8.741-6.263
5Y8.74110Y8.435+0.306
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4473.514-2.067
TTM2.4783.998-1.520
YOY5.3005.380-0.080
5Y8.7416.105+2.636
10Y8.4356.404+2.031

1.4. Solvency of Biovie Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biovie Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biovie Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.65 means that Biovie Inc assets are financed with 65.1% credit (debt) and the remaining percentage (100% - 65.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biovie Inc:

  • The MRQ is 0.651. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.604. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.651TTM0.604+0.047
TTM0.604YOY0.656-0.052
TTM0.6045Y1.286-0.682
5Y1.28610Y1.013+0.273
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6510.339+0.312
TTM0.6040.336+0.268
YOY0.6560.271+0.385
5Y1.2860.366+0.920
10Y1.0130.389+0.624
1.4.2. Debt to Equity Ratio

Measures if Biovie Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 186.9% means that company has $1.87 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biovie Inc:

  • The MRQ is 1.869. The company is just able to pay all its debts with equity.
  • The TTM is 1.596. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.869TTM1.596+0.272
TTM1.596YOY2.439-0.842
TTM1.5965Y0.893+0.703
5Y0.89310Y1.818-0.925
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8690.388+1.481
TTM1.5960.402+1.194
YOY2.4390.335+2.104
5Y0.8930.426+0.467
10Y1.8180.461+1.357

2. Market Valuation of Biovie Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biovie Inc generates.

  • Above 15 is considered overpriced but always compare Biovie Inc to the Biotechnology industry mean.
  • A PE ratio of -2.06 means the investor is paying $-2.06 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biovie Inc:

  • The EOD is -0.826. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.059. Based on the earnings, the company is expensive. -2
  • The TTM is -6.276. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.826MRQ-2.059+1.233
MRQ-2.059TTM-6.276+4.216
TTM-6.276YOY-5.438-0.838
TTM-6.2765Y-19.046+12.771
5Y-19.04610Y-18.620-0.426
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.826-2.264+1.438
MRQ-2.059-2.629+0.570
TTM-6.276-2.680-3.596
YOY-5.438-4.145-1.293
5Y-19.046-6.257-12.789
10Y-18.620-6.254-12.366
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biovie Inc:

  • The EOD is -1.174. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.928. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.367. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.174MRQ-2.928+1.753
MRQ-2.928TTM-5.367+2.440
TTM-5.367YOY-7.859+2.492
TTM-5.3675Y-76.118+70.751
5Y-76.11810Y-79.257+3.139
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.174-2.973+1.799
MRQ-2.928-3.333+0.405
TTM-5.367-3.553-1.814
YOY-7.859-5.605-2.254
5Y-76.118-8.376-67.742
10Y-79.257-8.865-70.392
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biovie Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 9.24 means the investor is paying $9.24 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biovie Inc:

  • The EOD is 3.706. Based on the equity, the company is fair priced.
  • The MRQ is 9.238. Based on the equity, the company is overpriced. -1
  • The TTM is 17.479. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD3.706MRQ9.238-5.533
MRQ9.238TTM17.479-8.241
TTM17.479YOY21.763-4.283
TTM17.4795Y18.517-1.038
5Y18.51710Y-274.456+292.974
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.7061.896+1.810
MRQ9.2382.115+7.123
TTM17.4792.093+15.386
YOY21.7632.884+18.879
5Y18.5173.542+14.975
10Y-274.4563.916-278.372
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biovie Inc.

3.1. Institutions holding Biovie Inc

Institutions are holding 4.48% of the shares of Biovie Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc0.6406035185015203476.087
2023-12-31BlackRock Inc0.63810350476278757388.6794
2023-12-31Geode Capital Management, LLC0.341501875894917535.5275
2023-12-31State Street Corporation0.3201757438637596.6509
2023-12-31Northern Trust Corp0.1983010892267932165.7282
2023-12-31Morgan Stanley - Brokerage Accounts0.15120830252769850.0624
2023-12-31Nuveen Asset Management, LLC0.1469080705810911.17
2023-12-31HPM Partners LLC0.07420.000240741510014.3094
2023-12-31Millennium Management LLC0.0673036962-22338-37.6695
2023-12-31Bank of America Corp0.066403645427844323.3914
2023-12-31Charles Schwab Investment Management Inc0.054502993518328157.9047
2023-12-31GRT Capital Partners LLC0.05360.03022945000
2023-12-31Virtu Financial LLC0.04570.002525077250770
2023-12-31Envestnet Asset Management Inc0.0399021911219110
2023-12-31Susquehanna International Group, LLP0.0355019503783167.0922
2023-12-31Crescent Grove Advisors, LLC0.03550.002719500850077.2727
2023-12-31Engineers Gate Manager LP0.03470.000719039190390
2023-12-31Atlantic Trust Group, LLC0.03240.00011781400
2023-12-31Barclays PLC0.0321017621165391528.5582
2023-12-31New York State Common Retirement Fund0.031401723500
Total 3.03980.03641669552+797911+47.8%

3.2. Funds holding Biovie Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Belfund SICAV Belinvest Equity A USD Acc1.04650.463641781200
2024-02-29Vanguard Total Stock Mkt Idx Inv1.0397041508900
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.36980.000214763700
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.28550.000311400000
2024-02-29iShares Russell 2000 Growth ETF0.26280.0012104937-122-0.1161
2023-12-31Fidelity Small Cap Index0.1840.00047344638659111.1306
2024-01-31TIAA-CREF Equity Index Instl0.18180.00027259600
2024-02-29Vanguard Russell 2000 ETF0.11080.00064422535608.7545
2024-01-31Fidelity Extended Market Index0.1090.00014352900
2023-12-31Russell 2000 Index Non-Lendable Fund E0.08990.00135884358840
2023-09-30BlackRock Extended Mkt Composite0.07910.000831570580.1841
2024-02-29Schwab Small Cap Index0.0750.00062993500
2023-12-31NT R2000 Growth Index Fund - L0.07140.00132848721432303.7845
2023-12-31Northern Trust Russell 2000 Growth Index0.07140.00132848721432303.7845
2023-12-31BlackRock Extended Equity Market K0.06880.000327457-55-0.1999
2024-02-29iShares Micro-Cap ETF0.06620.00362644400
2024-01-31Fidelity Nasdaq Composite Index0.05710.00022279800
2023-12-31BlackRock Russell 2000® Index NL F0.05230.00120881208810
2024-01-31Fidelity Total Market Index0.046401854100
2024-01-31EQ/2000 Managed Volatility IB0.03740.00051492700
Total 4.30490.47721718682+141729+8.2%

3.3. Insider Transactions

Insiders are holding 43.253% of the shares of Biovie Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-30Cuong V DoBUY100001.78
2023-09-05Steve GorlinSELL85603.05
2023-08-22Richard J BermanSELL108053.5
2023-06-07Richard J BermanSELL59845.81
2023-05-22Richard J BermanSELL50006.5

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Biovie Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.085+8092%0.046-102%0.004-129%0.003-132%
Book Value Per Share--0.1360.237-42%0.208-34%0.135+1%0.074+85%
Current Ratio--1.4712.074-29%5.354-73%8.763-83%8.591-83%
Debt To Asset Ratio--0.6510.604+8%0.656-1%1.286-49%1.013-36%
Debt To Equity Ratio--1.8691.596+17%2.439-23%0.893+109%1.818+3%
Dividend Per Share----0%-0%0.162-100%0.081-100%
Eps---0.153-0.170+11%-0.188+23%-0.281+84%-0.143-6%
Free Cash Flow Per Share---0.108-0.187+74%-0.132+23%-0.083-23%-0.042-61%
Free Cash Flow To Equity Per Share---0.018-0.117+551%150756.301-100%30151.276-100%15075.638-100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---3.264--------
Intrinsic Value_10Y_min---7.791--------
Intrinsic Value_1Y_max---0.193--------
Intrinsic Value_1Y_min---0.566--------
Intrinsic Value_3Y_max---0.682--------
Intrinsic Value_3Y_min---1.897--------
Intrinsic Value_5Y_max---1.294--------
Intrinsic Value_5Y_min---3.433--------
Market Cap27758892.840-149%69204996.000234253419.000-70%225602794.500-69%354234834.585-80%181676982.962-62%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio3.706-149%9.23817.479-47%21.763-58%18.517-50%-274.456+3071%
Pe Ratio-0.826+60%-2.059-6.276+205%-5.438+164%-19.046+825%-18.620+804%
Price Per Share0.505-149%1.2604.265-70%4.108-69%6.449-80%3.308-62%
Price To Free Cash Flow Ratio-1.174+60%-2.928-5.367+83%-7.859+168%-76.118+2500%-79.257+2607%
Price To Total Gains Ratio-489.635+60%-1220.697-345.969-72%6.461-18993%-107.437-91%-88.016-93%
Quick Ratio--1.4472.478-42%5.300-73%8.741-83%8.435-83%
Return On Assets---0.391-0.360-8%-0.365-7%-1.677+329%-0.944+142%
Return On Equity---1.122-0.959-15%-1.235+10%-1.802+61%-1.325+18%
Total Gains Per Share---0.001-0.085+8092%0.046-102%0.166-101%0.084-101%
Usd Book Value--7491235.00013024427.250-42%11413676.250-34%7424132.150+1%4058484.700+85%
Usd Book Value Change Per Share---0.001-0.085+8092%0.046-102%0.004-129%0.003-132%
Usd Book Value Per Share--0.1360.237-42%0.208-34%0.135+1%0.074+85%
Usd Dividend Per Share----0%-0%0.162-100%0.081-100%
Usd Eps---0.153-0.170+11%-0.188+23%-0.281+84%-0.143-6%
Usd Free Cash Flow---5909850.000-10277558.000+74%-7244876.750+23%-4535123.250-23%-2330947.550-61%
Usd Free Cash Flow Per Share---0.108-0.187+74%-0.132+23%-0.083-23%-0.042-61%
Usd Free Cash Flow To Equity Per Share---0.018-0.117+551%150756.301-100%30151.276-100%15075.638-100%
Usd Market Cap27758892.840-149%69204996.000234253419.000-70%225602794.500-69%354234834.585-80%181676982.962-62%
Usd Price Per Share0.505-149%1.2604.265-70%4.108-69%6.449-80%3.308-62%
Usd Profit---8401445.000-10862225.750+29%-10822125.750+29%-12306117.700+46%-6295203.350-25%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.001-0.085+8092%0.046-102%0.166-101%0.084-101%
 EOD+3 -5MRQTTM+14 -15YOY+11 -185Y+11 -2010Y+7 -24

4.2. Fundamental Score

Let's check the fundamental score of Biovie Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.826
Price to Book Ratio (EOD)Between0-13.706
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.447
Current Ratio (MRQ)Greater than11.471
Debt to Asset Ratio (MRQ)Less than10.651
Debt to Equity Ratio (MRQ)Less than11.869
Return on Equity (MRQ)Greater than0.15-1.122
Return on Assets (MRQ)Greater than0.05-0.391
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Biovie Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.500
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets21,490
Total Liabilities13,999
Total Stockholder Equity7,491
 As reported
Total Liabilities 13,999
Total Stockholder Equity+ 7,491
Total Assets = 21,490

Assets

Total Assets21,490
Total Current Assets20,562
Long-term Assets929
Total Current Assets
Cash And Cash Equivalents 20,227
Other Current Assets 335
Total Current Assets  (as reported)20,562
Total Current Assets  (calculated)20,562
+/-0
Long-term Assets
Property Plant Equipment 60
Goodwill 346
Intangible Assets 522
Long-term Assets  (as reported)929
Long-term Assets  (calculated)929
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,981
Long-term Liabilities18
Total Stockholder Equity7,491
Total Current Liabilities
Short-term Debt 10,244
Short Long Term Debt 10,195
Other Current Liabilities 3,738
Total Current Liabilities  (as reported)13,981
Total Current Liabilities  (calculated)24,177
+/- 10,195
Long-term Liabilities
Long-term Liabilities  (as reported)18
Long-term Liabilities  (calculated)0
+/- 18
Total Stockholder Equity
Common Stock4
Retained Earnings -320,338
Other Stockholders Equity 327,825
Total Stockholder Equity (as reported)7,491
Total Stockholder Equity (calculated)7,491
+/-0
Other
Capital Stock4
Cash and Short Term Investments 20,227
Common Stock Shares Outstanding 38,171
Liabilities and Stockholders Equity 21,490
Net Debt -9,966
Net Invested Capital 17,687
Net Working Capital 6,580
Property Plant and Equipment Gross 60
Short Long Term Debt Total 10,261



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-30
> Total Assets 
0
446
407
360
333
318
293
282
269
269
250
233
2,719
2,540
2,478
2,452
2,364
2,323
2,246
2,215
2,175
2,175
3,645
2,964
2,574
2,608
2,340
2,309
2,084
14,861
13,460
12,893
6,047
21,978
31,873
26,188
20,115
22,859
47,192
45,183
35,105
23,760
21,490
21,49023,76035,10545,18347,19222,85920,11526,18831,87321,9786,04712,89313,46014,8612,0842,3092,3402,6082,5742,9643,6452,1752,1752,2152,2462,3232,3642,4522,4782,5402,7192332502692692822933183333604074460
   > Total Current Assets 
0
446
407
360
333
318
293
282
269
269
250
233
131
9
5
35
5
22
2
28
46
46
1,630
1,007
674
765
554
581
413
13,248
11,903
11,394
4,605
20,594
30,547
24,792
18,780
21,590
45,990
44,047
34,041
22,764
20,562
20,56222,76434,04144,04745,99021,59018,78024,79230,54720,5944,60511,39411,90313,2484135815547656741,0071,630464628222535591312332502692692822933183333604074460
       Cash And Cash Equivalents 
0
446
407
345
333
318
288
279
267
267
250
233
124
9
5
35
5
22
2
28
46
46
1,630
972
340
249
3
4
37
13,196
11,876
11,351
4,512
20,488
30,392
24,507
18,642
21,231
45,749
31,276
19,461
21,215
20,227
20,22721,21519,46131,27645,74921,23118,64224,50730,39220,4884,51211,35111,87613,19637432493409721,630464628222535591242332502672672792883183333454074460
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,521
14,478
0
0
0014,47812,521000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
14
0
0
5
4
2
2
0
0
7
0
0
0
0
0
0
0
0
0
0
35
334
516
551
577
376
52
27
43
93
106
155
285
138
359
241
250
103
1,549
335
3351,5491032502413591382851551069343275237657755151633435000000000070022450014000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
2,588
2,531
2,474
2,416
2,359
2,302
2,244
2,187
0
2,130
2,015
1,958
1,900
1,843
1,786
1,728
1,671
1,614
1,556
1,499
1,442
1,384
1,327
1,397
1,335
1,269
1,202
1,135
1,064
996
929
9299961,0641,1351,2021,2691,3351,3971,3271,3841,4421,4991,5561,6141,6711,7281,7861,8431,9001,9582,0152,13002,1872,2442,3022,3592,4162,4742,5312,588000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
127
118
109
100
91
81
71
60
6071819110010911812700000000000000000000000000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
2,243
2,185
2,128
2,071
2,013
1,956
1,899
1,841
1,784
1,784
1,669
1,612
1,555
1,497
1,440
1,383
1,325
1,268
1,211
1,153
1,096
1,039
981
924
866
809
752
694
637
580
522
5225806376947528098669249811,0391,0961,1531,2111,2681,3251,3831,4401,4971,5551,6121,6691,7841,7841,8411,8991,9562,0132,0712,1282,1852,243000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
0
0
0
0
0000555000000000000000000000000000000000000
> Total Liabilities 
0
9
17
3
161
204
247
283
324
324
404
445
803
961
1,151
979
1,207
1,241
1,455
1,660
2,064
2,064
105
179
443
11,329
4,384
4,654
23,583
266
385
1,491
996
1,744
15,808
16,234
16,444
16,898
21,124
23,464
19,764
16,212
13,999
13,99916,21219,76423,46421,12416,89816,44416,23415,8081,7449961,49138526623,5834,6544,38411,3294431791052,0642,0641,6601,4551,2411,2079791,15196180344540432432428324720416131790
   > Total Current Liabilities 
0
9
17
3
161
204
247
283
324
324
404
445
803
961
1,151
403
631
665
879
1,084
1,238
1,238
105
179
443
11,329
4,384
4,654
23,520
203
322
1,428
996
1,260
4,358
4,317
4,169
4,096
7,797
16,004
14,495
13,212
13,981
13,98113,21214,49516,0047,7974,0964,1694,3174,3581,2609961,42832220323,5204,6544,38411,3294431791051,2381,2381,0848796656314031,15196180344540432432428324720416131790
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
10
347
10
576
25
0
0
0
0
0
2
52
473
849
0
0
0
0
0
0
29
39
40
42
6,434
9,150
9,385
10,244
10,2449,3859,1506,43442403929000000849473522000002557610347102100000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
10
347
10
576
601
0
0
0
0
0
2
52
473
849
0
0
0
0
0
0
0
0
0
0
6,391
9,105
9,339
10,195
10,1959,3399,1056,39100000000008494735220000060157610347102100000000000000
       Accounts payable 
0
9
0
3
0
2
5
1
1
1
1
1
294
389
517
330
471
468
629
746
884
884
105
179
443
684
1,085
1,300
1,259
203
322
1,428
996
679
1,663
1,206
2
3
3,245
5
3
3
0
03353,245321,2061,6636799961,4283222031,2591,3001,085684443179105884884746629468471330517389294111115203090
       Other Current Liabilities 
0
0
17
0
161
202
242
283
323
323
404
444
510
572
635
73
160
198
879
0
0
354
0
0
0
11,327
3,247
4,181
21,412
0
0
0
996
1,260
4,358
4,288
4,130
4,055
4,510
9,570
5,345
3,827
3,738
3,7383,8275,3459,5704,5104,0554,1304,2884,3581,26099600021,4124,1813,24711,327000354008791981607363557251044440432332328324220216101700
   > Long-term Liabilities 
0
9
0
3
0
2
5
1
0
1
1
1
0
389
517
576
576
576
576
576
0
826
105
179
443
2
1,137
473
63
63
63
63
0
484
11,450
11,916
12,274
12,802
13,327
7,460
5,270
3,000
18
183,0005,2707,46013,32712,80212,27411,91611,4504840636363634731,137244317910582605765765765765765173890111015203090
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63
63
0
0
0
0
12,139
12,725
13,261
0
0
0
0
000013,26112,72512,13900006363000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
576
576
576
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
484
339
194
48
0
0
0
0
0
0
00000048194339484000000000000000576576576000000000000000
> Total Stockholder Equity
0
437
390
357
171
115
46
-1
-54
-54
-155
-211
1,916
1,578
1,327
1,473
1,157
1,082
791
555
111
111
3,541
2,785
2,131
-8,721
-2,044
-2,344
-21,499
14,596
13,075
11,402
5,050
20,234
16,065
9,955
3,671
5,961
26,068
21,718
15,340
7,548
7,491
7,4917,54815,34021,71826,0685,9613,6719,95516,06520,2345,05011,40213,07514,596-21,499-2,344-2,044-8,7212,1312,7853,5411111115557911,0821,1571,4731,3271,5781,916-211-155-54-54-1461151713573904370
   Common Stock
0
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
10
10
10
32
32
51
65
1
1
1
1
1
1
2
2
2
2
2
3
3
4
4
4
4
44443322222111111655132321010109999999999999999990
   Retained Earnings Total Equity0000-277,073-261,386-250,9700000-93,353-90,360000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17
177
0
0
0017717000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
103,434
104,754
0
0
0
0
254,638
267,344
303,137
0
0
0
0
0000303,137267,344254,6380000104,754103,434000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
500
500
514
502
504
506
508
510
510
513
514
2,912
2,925
3,032
3,356
3,483
4,071
4,282
4,739
0
4,870
9,267
9,360
9,342
19,397
19,472
19,539
19,539
101,897
103,434
104,754
229,934
250,658
251,903
252,833
254,638
267,344
303,137
313,812
316,386
319,480
327,825
327,825319,480316,386313,812303,137267,344254,638252,833251,903250,658229,934104,754103,434101,89719,53919,53919,47219,3979,3429,3609,2674,87004,7394,2824,0713,4833,3563,0322,9252,9125145135105105085065045025145005000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-267
Gross Profit-267-267
 
Operating Income (+$)
Gross Profit-267
Operating Expense-45,080
Operating Income-45,080-45,347
 
Operating Expense (+$)
Research Development33,300
Selling General Administrative11,552
Selling And Marketing Expenses0
Operating Expense45,08044,851
 
Net Interest Income (+$)
Interest Income562
Interest Expense-4,300
Other Finance Cost-0
Net Interest Income-3,738
 
Pretax Income (+$)
Operating Income-45,080
Net Interest Income-3,738
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-50,256-43,643
EBIT - interestExpense = -48,818
-45,956
-45,956
Interest Expense4,300
Earnings Before Interest and Taxes (EBIT)-44,518-45,956
Earnings Before Interest and Taxes (EBITDA)-44,289
 
After tax Income (+$)
Income Before Tax-50,256
Tax Provision-0
Net Income From Continuing Ops-50,256-50,256
Net Income-50,256
Net Income Applicable To Common Shares-50,256
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses45,080
Total Other Income/Expenses Net-1,4373,738
 

Technical Analysis of Biovie Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biovie Inc. The general trend of Biovie Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biovie Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biovie Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.5499 < 0.8902 < 1.

The bearish price targets are: 0.445.

Tweet this
Biovie Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biovie Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biovie Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biovie Inc.

Biovie Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiovie Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biovie Inc. The current adx is .

Biovie Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biovie Inc.

Biovie Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biovie Inc.

Biovie Inc Daily Relative Strength Index (RSI) ChartBiovie Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biovie Inc.

Biovie Inc Daily Stochastic Oscillator ChartBiovie Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biovie Inc.

Biovie Inc Daily Commodity Channel Index (CCI) ChartBiovie Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biovie Inc.

Biovie Inc Daily Chande Momentum Oscillator (CMO) ChartBiovie Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biovie Inc.

Biovie Inc Daily Williams %R ChartBiovie Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biovie Inc.

Biovie Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biovie Inc.

Biovie Inc Daily Average True Range (ATR) ChartBiovie Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biovie Inc.

Biovie Inc Daily On-Balance Volume (OBV) ChartBiovie Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biovie Inc.

Biovie Inc Daily Money Flow Index (MFI) ChartBiovie Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biovie Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Biovie Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biovie Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.500
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biovie Inc with someone you think should read this too:
  • Are you bullish or bearish on Biovie Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biovie Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biovie Inc

I send you an email if I find something interesting about Biovie Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biovie Inc.

Receive notifications about Biovie Inc in your mailbox!